Date: 2025-09-08
ASML is the world’s dominant supplier of advanced photolithography systems used to print patterns on silicon wafers, especially the only company shipping production EUV machines. Its customers are the leading foundries and chip manufacturers (TSMC, Samsung, Intel, others). The business is capital-intensive, highly technical, and tied to the semiconductor capital expenditure cycle, yet it benefits from multi-year R&D, customer lock-in, long lead times and extremely high barriers to replication.
Is the business model simple and sustainable?
Simple to describe. ASML sells extremely complex machines and service them, but the economics are sustainable because of technology barriers, tight customer relationships, and long product lifecycles. Sustainability depends on continued semiconductor demand and ASML maintaining technological leadership.
Does the company have a durable competitive advantage (moat)?
Yes, a very wide tech moat. ASML’s position in EUV lithography (and long R&D lead time) creates quasi-monopoly dynamics. That’s reflected in very high gross margins (52% TTM) and ROIC (~25%). That moat is real and unusual.
Who are the company’s competitors, and how is it positioned?
Competitors in lithography historically include Nikon and Canon (mostly DUV lithography). For the most critical EUV systems there effectively are no close substitutes; ASML dominates. That positioning gives ASML pricing power and strategic customer dependency.
Is management competent, honest, and aligned with shareholder interests?
Yes, high ROIC, growing free cash flow, share count shrinking by −5.75% (share repurchases), and modest dividends imply management returns capital and prioritizes value creation. The very high margins and low acquisition spend ($85.49M over 5 years) show disciplined capital allocation.
Is the stock undervalued compared to its intrinsic value?
- Current price used: ≈ $796 / share.
- DCF intrinsic (base): $660.6/share therefore price > intrinsic
- MEV conservative/moderate: $389.9 / $487.3 therefore both well below price.
Conclusion: at the current price, the stock looks at least modestly overvalued vs the DCF base and materially overvalued vs conservative MEV. If you use a lower discount rate (8%) or assume stronger multi-year growth, the DCF pushes fair value above the current price. Thus the verdict depends on how bullish you are about multi-year growth and what WACC you accept.
Does the company use its capital efficiently?
Yes. ROIC ~ 24–25% is excellent. Buybacks (shrinking shares) plus a payout show capital returned to shareholders. Capital reinvestment (R&D and capex) is high but has produced dominant technology.
Does the company generate strong free cash flow?
Yes. TTM FCF = $10.90B; 5-yr avg FCF = $7.92B. FCF margins are healthy. Price/FCF (TTM) = ~28.4. This is not cheap vs peers but consistent with a high-quality growth firm.
Is the balance sheet strong?
Yes. EV only modestly above market cap implies manageable net debt (~$23.5B). High cash generation, low acquisitiveness, and strong margins point to a sound balance sheet.
How consistent is the company’s earnings and revenue growth?
Very consistent historically 5-yr revenue CAGR ~20.26% and 10-yr ~18.05%: that’s strong, sustained growth. Earnings and margins have been robust, reflecting both pricing power and cost structure.
What is the margin of safety in this investment?
With the assumptions above, no margin of safety at ~ $796 because current price > DCF fair value ($660). A comfortable margin of safety (25%) relative to my DCF would require a price below ≈ $495.
What are the company’s biggest risks?
- Semiconductor cyclical downturns: capex cuts reduce orders
- Geopolitical/export controls: restrictions on where ASML can sell advanced tools
- Customer concentration: a few big chipmakers account for large orders
- Supply chain or manufacturing bottlenecks: that slow delivery.
- Technology risk: if a rival breakthrough, or customers adopt alternative lithography approaches. The probability of this happening is very low today.
- Valuation risk: market paying a premium for secular optimism
Is the company diluting shareholders through issuance or bad acquisitions?
No. Shares outstanding down.
Is this company cyclical or stable? How would it perform in a recession?
Cyclical in orders (capex), but structurally indispensable for advanced chipmaking. In a recession, near-term orders and margins may be pressured; in the medium/long term its installed base and critical role should preserve profitability. Expect volatility, not complete collapse.
What would this company look like in 5–10 years?
If ASML maintains EUV leadership and the industry keeps growing: larger installed base, steady high margins, higher absolute FCF, bigger R&D pipeline (next-gen lithography), and continued cash returns. If geopolitical or tech disruption occurs, growth could be impaired.
Would I still buy this stock if the market closed for 5 years?
Yes, assuming the semiconductor industry compound growth continues and ASML maintains monopoly-level technology advantage, ASML is a reasonably safe five-year “buy and hold” for exposure to secular chip demand. However, you’d want to buy at or below a conservative fair value (my DCF baseline or lower), otherwise you overpay for future growth.
What is PEGY and what does this indicate?
PEGY = PE / (expected earnings growth% + dividend yield%). This adjusts valuation for growth and income. PEGY ≈ 1.26 for ASML (using your 5-yr revenue CAGR 20.26% as growth proxy and dividend 0.95%). A PEGY near 1.0 often signals “fair” valuation for growth. 1.26 suggests the market is paying a modest premium for the expected growth.
Is the company reinvesting in value-accretive ways or returning cash efficiently?
Yes. ROIC (>24%), strong FCF, shrinking share count, modest dividends. R&D and capex are substantial (as required) and appear to be generating outsized returns, which is exactly what you want from reinvestment.
Why is this stock mispriced or priced correctly? What’s the market missing?
- Why priced richly: the market is paying for strong secular growth (AI, cloud, advanced nodes), durable monopoly-like tech and a multi-year backlog.
- Why that could be wrong: if semiconductor capex slows, or export restrictions shrink addressable markets, the premium compresses. The market may be too optimistic about sustained double-digit FCF growth at current multiples.
What assumptions am I making and what would prove them wrong?
Key assumptions I used:
- Meaningful multi-year FCF growth (12% to 7% schedule) and a 9% discount rate.
- Net debt roughly as current snapshot.
What would disprove these: - Material and persistent declines in FCF or margins.
- Loss of technological leadership or widespread substitution.
- Significant new regulation restricting markets or customers.
How does this investment fit into an overall portfolio strategy?
- Core growth/quality holding for a long-term portfolio that can tolerate cyclicality and wants semiconductor exposure.
- Not a defensive or income stock. A value investor should size position carefully given current premium.
Final intrinsic-value judgement and recommendation
- DCF base fair value ≈ $660.6 / share (with my explicit growth and 9% discount rate).
- MEV fair-value range ≈ $389.9 (conservative) to $487.3 (moderate) depending on the multiple you are willing to ascribe.
- Implied current price used ≈ $796 the stock trades above my DCF base and well above conservative MEV.
My practical recommendation as a fact-based long-term value investor: - If you already own ASML: HOLD, this is a high quality business with real moat; trim only to rebalance or if your position is outsized.
- If you do not own ASML and are looking to buy: Wait or accumulate on weakness. I would look to buy on meaningful weakness below the DCF baseline (~$660) and build a more attractive position below $495
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Always perform your own due diligence or consult with a financial advisor before making investment decisions.
